A Study of Linperlisib (YY-20394) in Combination With Rituximab in Patients With Relapsed/Refractory Indolent NHL

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Linperlisib (YY-20394) in Combination With Rituximab in Patients With Relapsed/Refractory Indolent NHL	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Not yet recruiting	Phase 1 / Phase 2	2025-05-21		NCT06981988

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jiangsu HengRui Medicine Co., Ltd.	132

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials